chrisvoncsefalvay/vaers-outcomes huggingface dataset:
March 4 - J&J Covid Vaccination  March 5 - Woke up feeling terribly under the weather; sinus inflammation/chills/fatigue/pressure in ears/pain in teeth (upper back molars),  swollen glands  - just plain "ill"  Week of March 8 - See above, the same  March 9 - Appointment at Primary Care Clinic due to March 5th symptoms and a 1-day bout of diarrhea   Diagnosis ?cold, sinus issues? - try Mucinex/Tylenol / Covid Test = Negative  Mid-March:  fever blister appears for a few days and ringing in my ears (noise) increases.  Fever blister lasts about 4 days.  Week of March 15 - Same Symptoms as March 5 plus another 1-day bout of diarrhea  Sunday, March 21 - stomach cramps / diarrhea - chills/overwhelming fatigue - same sinus issues as March 5  Week of March 22nd - equilibrium is off and starts to become an issue - 3 nights of vertigo but not severe during that week.  Last vertigo attack was in 2018.  March 28th - sinus situation the same, diarrhea again, start Pepto Bismol regime based on past microscopic colitis issues  Mucus is thin and clear, just started to discharge.  March 31st - Schedule another appt at Primary Care Clinic due to ?status quo? - this doctor thinks inflammation and prescribes prednisone (2) 20 mg for 5 days  - Covid Test / Strep Test / Influenza Tests = Negative  March 31 - April 4 / Prednisone:  Visibly more stuffed up. Tooth/nerve pain increased from a 3 to a 7; didn't take the final days dose.  After stopping my head felt numb.  Vertigo stopped; equilibrium still off.  Increased tinnitus and increased pressure/burning under my eyes and around my cheekbones.    April 5 - 6 - New symptom appeared approximately a week ago; tightness in throat, difficulty swallowing.   Still experiencing tooth nerve pain (sinus cavities).  Woke up soaked the last 2 nights.   Noticed increased difficulty concentrating "brain fog".
3/11/21 Developed shingles 3/14/21 E/R For shingles medicines 3/24/21 DR. DIAGNOSED w Pneumonia & sent to E/R.
pt recv vax;devel neck pain,hip pain & flu like sx w/ 2nd dose;recovered w/in 2 days;
Pregnant; injection site soreness; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of MATERNAL EXPOSURE DURING PREGNANCY (Pregnant) and VACCINATION SITE PAIN (injection site soreness) in a 39-year-old female patient (gravida 3, para 2) who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Symphysis pubis dysfunction. Concurrent medical conditions included Allergy to antibiotic (Tetracycline), Thyroid activity decreased (Treatment change: dose doubled due to pregnancy) since 01-Jan-2018, Gestational diabetes (borderline gestastional diabeties) since 02-Mar-2021 and Sleep apnea (Worsening due to pregnancy). Concomitant products included ONDANSETRON (ZOFRAN [ONDANSETRON]) for Nausea, FLUTICASONE PROPIONATE (FLONASE [FLUTICASONE PROPIONATE]), CETIRIZINE HYDROCHLORIDE (ZYRTEC [CETIRIZINE HYDROCHLORIDE]), PRENATAL VITAMINS [ASCORBIC ACID;BETACAROTENE;CALCIUM SULFATE;COLECALCIFEROL;CYANOCOBALAMIN;FERROUS FUMARATE;FOLIC ACID;NICOTINAMIDE;PYRIDOXINE HYDROCHLORIDE;RETINOL ACETATE;RIBOFLAVIN;THIAMINE MONONITRATE;TOCOPHERYL ACETATE;ZINC OXIDE], COLECALCIFEROL (VITAMIN D [COLECALCIFEROL]), DOCUSATE SODIUM (STOOL SOFTENER) and CALCIUM, MAGNESIUM (CALCIUM + MAGNESIUM) for an unknown indication.    On 12-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. The patient's last menstrual period was on 25-Aug-2020 and the estimated date of delivery was 01-Jun-2021. On 12-Mar-2021, the patient experienced MATERNAL EXPOSURE DURING PREGNANCY (Pregnant) and VACCINATION SITE PAIN (injection site soreness). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) beginning around the  twenty-eighth week of the pregnancy.  The patient was treated with PARACETAMOL (TYLENOL) for Adverse event, at an unspecified dose and frequency. On 14-Mar-2021, VACCINATION SITE PAIN (injection site soreness) had resolved. At the time of the report, MATERNAL EXPOSURE DURING PREGNANCY (Pregnant) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 30-Sep-2020, Pregnancy test: positive (Positive) positive. On 02-Mar-2021, Glucose tolerance test: borderline gestastional diabeties (Inconclusive) borderline gestastional diabeties.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   On 13 Oct 2020, genetic testing was done (results reported as "none")  Patient had 02 live births and pregnancy end date was reported as 13-Oct-2015 and 27-Dec-2017 respectively.
Pt received his first dose of the Moderna COVID19 vaccine and reported feeling numbness and tingling in his fingers on the left hand. Pt had his injection on the left deltoid. BP 154/104 HR 97 O2 Sat 98%  Repeat BP 160/94 HR 93 O2 Sat 98%   EMS was already on site, evaluated pt. Pt?s symptoms resolved. BP with EMS 134/86. Pt signed refusal for transport to the hospital with  EMS.  Pt was advised to contact his PCP prior to his 2nd dose.
high fever-not taken; febrile seizure 35-40 seconds; no tx necessary;
She got real sick; Felt hot all over; Felt sick like she had the flu; Throat was dry; Did not want to eat anything; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (She got real sick), BODY TEMPERATURE INCREASED (Felt hot all over), ILLNESS (Felt sick like she had the flu), DRY THROAT (Throat was dry) and DECREASED APPETITE (Did not want to eat anything) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced ILLNESS (She got real sick), BODY TEMPERATURE INCREASED (Felt hot all over), ILLNESS (Felt sick like she had the flu), DRY THROAT (Throat was dry) and DECREASED APPETITE (Did not want to eat anything). At the time of the report, ILLNESS (She got real sick), BODY TEMPERATURE INCREASED (Felt hot all over), ILLNESS (Felt sick like she had the flu), DRY THROAT (Throat was dry) and DECREASED APPETITE (Did not want to eat anything) outcome was unknown.            Treatment details included Cold towel.  No relevant concomitant medications were reported.
Since receiving the 1st shot on 3/16 I've had a pretty constant case of covid arm. It only goes away when I sleep. When I'm awake it's a constant, aching soreness just distal to the deltoid. It often radiates to my wrist, shoulder, and/or neck.  I've tried ibuprofen, acetaminophen, and naproxen with no relief. The only thing that temporarily dulls the pain is ice. It doesn't affect my movement or mobility.
Auxiliary lymph node pain on left side > 5 days.; Auxiliary lymph node welling on left side > 5 days.; This is a spontaneous report from a non-contactable consumer, the patient. An adult male patient of unknown age received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER 2613) via an unspecified route of administration in the left arm on 12Apr2021 as a single dose for COVID-19 immunisation. Medical history was not reported. The patient had no known allergies to medications, food or other products. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN 6206) via an unspecified route of administration in the left arm on 22Mar2021 as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications include levothyroxine sodium (SYNTHROID) for unknown indication from an unknown date and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 13Apr2021 the patient experienced auxiliary lymph node pain/swelling on left side for more than 5 days. Therapeutic measures were not taken as a result of the events. The events did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19.The clinical outcome of the event auxiliary lymph node pain/swelling on left side for more than 5 days was resolving.  No follow-up attempts are possible. No further information is expected.  .
Baby developed red rash on face  about 5 minutes after receiving vaccines according to guardian. When I examined baby had hives on face and no swelling. Lungs were clear w/o wheezing. Within 5 minutes the rash was starting to fade. Baby was given benadryl 6.25 mg and after 15 minutes rash was completely gone.
Parasthesia left side of face. It was debilitating and painful. I had allergy testing and also an mri to rule out other neurological conditions. The outcome was that it was a transient vaccine reaction and should go away. I still feel slight tingling but am almost 100%. It?s been 3 months. I lost 10 pounds and felt very ill.
mother called 10/2/09 stating that child not moving his leg, "dragging it behind him" when he walks. denies swelling. limping. mother had given advil once for pain the first day only. Advised Advil for pain and to f/u with child's pediatrician. phone call several hours later to mother who stated that child was moving leg more after advil.  follow up phone call 10/5 in which mother told me she administered advil over the weekend and child was "back to normal" and riding his bike and playing yesterday.
This spontaneous report as received from a health professional refers to multiple unspecified patients of unknown age and gender. Information regarding the patients medical history and concurrent conditions were not provided. On unknown dates the patients were vaccinated with improperly stored M-M-R II (Lot number-L019989, expiry date-01-JUN-2017). No adverse effects were reported. No laboratory tests were reported. It was also reported that the temperature was 27C for a time frame of 29 hours and that there was no previous temperature excursion. No product quality complaint (PQC) was involved. No further information was provided. This is one of the two reports from the same reporter. Additional information has been requested.
Case number PHEH2011US04310 is an initial spontaneous report received from a consumer who is also a health care professional on 15 Sep 2011: This report refers to an adult male patient. His medical history included diabetes and concomitant medications included insulin shots. He had received three to four cortisone shots in the past that brought his blood sugar level high. When he got the cortisone shots he would adjust his basal insulin two to two and a half times higher and adjusted his bolus insulin up to two to three times higher than normal. He had received flu shots every year in the past and it had never affected his blood sugar level. He was vaccinated with FLUVIRIN (batch number, 1101201) intramuscularly on 13 Sep 2011. After the FLUVIRIN shot he adjusted his bolus insulin lower than usual and later that evening he experienced high blood sugar of 530 (units and normal range not reported) which persisted all day on 14 Sep 2011 as well. He then had another bolus shot and his blood sugar was still not normal. On 14 Sep 2011, he was taken to the emergency room (ER) where the nurse recommended to change everything on the pump and to switch the site. He was on his third bolus shot at the time of reporting and did another site switch. The sugar fluctuations after the cortisone shots usually lasted for three days and this was the second day after FLUVIRIN shot, he was not back to normal yet. But he was taking more insulin now. No further information about the final outcome and causality was reported.
A 56 year old male pt experienced inadequate rabies antibody titers while receiving RabAvert therapy. The pt received an initial series of RabAvert in 2002 for pre exposure prophylaxis along with a Hep B vaccination series. He was administered a booster series of RabAvert injections on 13Jan04, 20Jan04 and 13Feb04 for pre exposure prophylaxis. The pt had no past medical history and takes no concomitant medications. On 28Jun04 an enzyme linked immunosorbent assay (ELISA) test was performed with a result of less than 0.5. The physician assigned to his work area and was informed that the level indicated an inadequate antibody titer. The treatment plan was for the pt to have another RabAvert booster and then a Rapid Fluorescent Focus Inhibition Test (RFFIT) will be performed.
Decreased milk supply and fussy infant who was 5 weeks old at second dose and 6 days old at first dose.  This side effect happened with both doses and there are no other known reasons for the symptoms.  Also body aches, headaches and sore injection site. Decreased milk supply and fussy infant is ongoing since second dose and other side effects lasted 24 hours.
This spontaneous report was received from a 57 year old female patient reporting on herself. The patient had no pertinent medical history, drug reactions or allergies. On 15-OCT-2015, the patient was vaccinated with PNEUMOVAX 23 injection, route of administration reported as "intramuscular or subcutaneous", (dose, dose number, lot#, expiry date and site of administration were not reported). The patient had no concomitant medications. On 16-OCT-2015, the patient experienced swollen shoulder (unspecified shoulder) and fever. On an unknown date in 2015, the patient saw her physician who stated they were unsure of why she suffered these reactions and no specific treatment was provided by her physician. On 31-DEC-2015, the patient experienced anaphylactic reaction to an unspecified food source. On 12-JAN-2016, after seeing an allergist, the patient was diagnosed with allergies, but to unknown sources. The patient underwent an unspecified allergy testing, on an unknown date. The patient stated that she experienced multiple allergies and anaphylactic episodes since receiving the PNEUMOVAX 23 (dates unspecified). An unspecified treatment was given for the events. The outcome of anaphylactic reaction and multiple allergies was reported as recovering. The outcome of swollen shoulder and fever was reported as recovered on approximately 30-OCT-2015 and 23-OCT-2015 respectively. Upon internal review the event of multiple anaphylactic episodes including anaphylactic reaction to an unspecified food source was considered to be medically significant. The reporter considered all events to be related to PNEUMOVAX 23. Additional information has been requested.
Pt received 3 vaccines Tdap and MCV 4 in the Left Arm and then HPV9 last in the left arm.  Immediately after receiving the last vaccine the patient stiffened with her eyes rolled back leading to LOC. Patient was then lowered to the ground and regained consciousness about 10-20 seconds after the after the start of the episode, pt was given a juice box as well as an ammonia inhalant.  about 2-3 minutes after regaining consciousness, Pt stated she felt normal.  We waited for a about 5 minutes and then started slowly moving her to a sitting position. She sat for about 5 minutes before goin go the standing position.  Pt still stating she " feels normal" so we walked to the waiting room and was instructed to sit for another 15 minutes before leaving, and to notify a nurse if dizziness or lightheadedness returns.  Pt was educated on future visits, to let the nurse know there is history of syncope with shots and the importance of eating before receiving any invasive procedures.
Elevated liver enzymes and low platelet counts, kidneys shutting down, liver shutting down. Estimated delivery date was July 31, 2018, Patient needed emergency c-section to save mother's life and babies life.
pt recvd vax;unresponsive w/ body convuls;sz lasted less than 30 secs;red petichiae rash below inj site noted;epi,dph given;to hosp
Information has been received from a health professional concerning a patient who was vaccinated with a dose of ROTATEQ. It was reported the patient developed rotavirus gastroenteritis following vaccination with ROTATEQ. The healthcare worker did not have specific information at the time of the report. A product quality complaint was not involved. Additional information has been requested.
This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.An 86 year-old female patient received bnt162b2 (BNT162B2), administration date 04Feb2021 (Batch/Lot number: unknown) at the age of 86 years as dose 1, single and administration date 25Feb2021 (Batch/Lot number: unknown) as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported.The following information was reported: BALANCE DISORDER (non-serious) with onset 04Feb2021, outcome "not recovered", described as "abrupt change in stability in her legs/unsteadiness in participant's legs/leg muscles are not as stable"; GAIT DISTURBANCE (non-serious) with onset 04Feb2021, outcome "not recovered", described as "wobbliness". Relevant laboratory tests and procedures are available in the appropriate section.Additional information: The patient reported that she walks a lot and is a solid walker. She does not use walkers or canes. She spoke with a very qualified Physical Therapist and was told sometimes her body, even though the Pfizer vaccine is good for her, the body says wait a minute. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Initial report received from nurse on 13 Jan 2010: A child patient under the age of 4 years was vaccinated with pandemic influenza virus vaccine (manufacturer unknown) on 13 Jan 2010. No adverse event was reported.
Within 2-3 hours of vaccine, patient developed low grade fever and inconsolable crying. Baby seemed aggravated by being touched or moved. Waves of inconsolable crying continued for 2days. Parents did not seek medical care during this time. Patient did not have any signs of upper respiratory infection or teething according to parents. Event was reported to physician at next well child visit.
Patient reported a red raised area around the injection site starting the  day after his 2nd Moderna vaccination. He also reported malaise and overall body  aches which were mild in nature. These abated after 48 hours with no lasting  effects.
Breakthrough case admission after three vaccines Pfizer 3/10/21 Lot# EN699;  Pfizer 3/31/21 Lot# EW0150;  Pfizer 8/24/21 Lot# FC318
Patient received Moderna vaccine under the age of 18 years old. Patient had no adverse reactions except a sore arm.
Some doses that may have been administered past 30 days from being thawed/The vaccines were applied to patients after being refrozen; Some doses that may have been administered past 30 days from being thawed/The vaccines were applied to patients after being refrozen; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Some doses that may have been administered past 30 days from being thawed/The vaccines were applied to patients after being refrozen) and PRODUCT STORAGE ERROR (Some doses that may have been administered past 30 days from being thawed/The vaccines were applied to patients after being refrozen) in a 68-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 22-Apr-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Apr-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Some doses that may have been administered past 30 days from being thawed/The vaccines were applied to patients after being refrozen). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Some doses that may have been administered past 30 days from being thawed/The vaccines were applied to patients after being refrozen). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Some doses that may have been administered past 30 days from being thawed/The vaccines were applied to patients after being refrozen) and PRODUCT STORAGE ERROR (Some doses that may have been administered past 30 days from being thawed/The vaccines were applied to patients after being refrozen) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant information was reported. No treatment information was reported.  It was reported that the first shipment was received  on 15-Mar-2021, and since they didn't know it was refrozen, they used it beyond 14-April. They had a sheet from the first shipment, that showed the transport conditions up to the time they had it. The earliest time on this sheet was 15-Mar-2021 at 6.45 AM, and the graph started at 0.4°C at 6.45AM, it had a 10-15 minutes time stamp, and stated that between 6:45 and 7AM it had -2°C. Once they received the shipment, they placed it at freezer temperature, at around -20°C. After that, they removed a vial from the freezer to use it that same day, whenever they needed a vial to administer the vaccine. The doses were viable up to 14-Apr-2021, the 30 days since it was thawed. The highest temperature could confirmed for the one shipment was 0.4 degrees Celsius, and the lowest was about -20 degrees Celsius.
flu; Initial information received on 19-Nov-2020 regarding an unsolicited valid non-serious case received from a consumer or non-healthcare professional via social media.  This case involves a 56-years-old patient who experienced flu (influenza), when received vaccine INFLUENZA VACCINE.  The patient's medical history, past medical treatment, vaccination, concomitant medication and family history were not provided.   On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer lot number not reported via an unknown route at an unknown administration site for prophylactic vaccination.  On an unknown date, the patient developed a non-serious flu (influenza) unknown latency following the administration of INFLUENZA VACCINE.  Laboratory details were not reported.   It was not reported if the patient received a corrective treatment.  The event outcome was unknown for influenza.  There will be no information available on the batch number for this case.
Body pain; This case was reported by a consumer via interactive digital media and described the occurrence of general body pain in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On 7th February 2023, the patient received the 2nd dose of Shingles vaccine. On 8th February 2023, 1 days after receiving Shingles vaccine, the patient experienced general body pain. On an unknown date, the outcome of the general body pain was unknown.   It was unknown if the reporter considered the general body pain to be related to Shingles vaccine.     Additional Information: GSK Receipt date: 08-Feb-2023. Reporter's Comment: This case was reported by patient via interactive digital media. Patient stated that he/she had body pain. Additional Supportive Information: Follow-up would not possible as no contact details were available.
Headache, Fatigue, chills, injection site pain and swelling, joint pain (r arm) Narrative:
5 days post vaccination, client observed an increase in soreness at injection site (left deltoid), redness, inflammation and pain described as burning with tenderness and itchyness. The next morning, client observed spots of inflammation at her left bicep area approximately 4.5 inches at the widest point. the area was red, swollen, warm to the touch but without pain or soreness.